Back to Authors

Diaz-Galvan, Patricia

0000-0001-6155-5585

Mayo Clinic

Mayo Clinic and Foundation.

Citations 13

Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies

Neurology | November 29, 2022 | Volume: 100 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000201579 | PMID 36443011

MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies

No container title available | September 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2015284/v1

Abstract Background. Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. Objectives. We used data-driven analysis of MRI data to investigate DLB subtypes. Methods. We included 165 probable DLB from the Mayo Clinic and 3 centers from the European DLB consortium and performed a hierarchical cluster analysis to identify subtypes based on gray matter (GM) volumes. To characterize the subtypes, we used demographic and clinical data, as well as β-amyloid and cerebrovascular biomarkers at baseline, and cognitive decline over three years. Results. We identified 3 subtypes: an older subtype with reduced cortical GM volumes, worse cognition, and faster cognitive decline (n=49, 30%); a subtype with low GM volumes in fronto-occipital regions (n=76, 46%); and a subtype of younger patients with the highest cortical GM volumes, proportionally lower GM volumes in basal ganglia and the highest frequency of cognitive fluctuations (n=40, 24%). Conclusions. This study shows the existence of MRI subtypes in DLB, which may have implications for clinical workout, research, and therapeutic decisions.
The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline

Aging | August 25, 2021 | Volume: 13 | Issue: 16 | Pages: 19963-19977

10.18632/aging.203467 | PMID 34433132